Open for inclusion

Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor that has become radiologically undetectable with treatment

Cancer type: Sarcoma

Phase: II

Principal Investigator: Bruland Øyvind

Country: NO

Keywords: Norway, Oslo, GIST, imatinib

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02924714?term=stop+GIST&rank=1